{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2026/regulation-4",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2026/regulation-4.json",
  "legislation": "uksi/2026/961",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-amendment-no-2-regulations-2026",
  "path": "regulation/4",
  "kind": "regulation",
  "number": "4",
  "heading": "Amendments to regulation 52",
  "text": "(1) Regulation 52 (notification of applications for outline consent and premises approval) is amended as follows.\n(2) In paragraph (1), at the beginning, for “Where” substitute “Subject to paragraph (12), where”.\n(3) After paragraph (11) insert—\n“(12) Where NHS England is required to refuse an application pursuant to regulation 51(5) or (6), NHS England need not give notice of that application to any person under this regulation before refusing that application.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Regulation 52 was amended by S.I. 2023/1071."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2026/961/regulation/4",
    "retrieved_at": "2026-10-28T20:55:54.559820+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}